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Abstract
Diabetes is a leading cause of hospitalization and readmission in the United States. The
30-day readmission rate for diabetic patients represents substantial costs to the nation’s
health care system. The purpose of this quantitative study was to examine the relationship
between primary payer status and hospital readmission rates among individuals whose
primary or secondary reason for admission was Type 2 diabetes mellitus (T2DM).
Secondary data from the Healthcare Cost Utilization Program Nationwide Database of
the 2015 National Readmission Database was analyzed. Participants in the data set
included 41,068 diabetes patients, 53.8% of whom were female. The average age was
67.26, and the majority had diabetes with complications (62.1%). The Donabedian
framework was applied for the analysis. Results of logistic regression analysis showed
that possession of Medicare and lack of insurance were significant predictors of being
readmitted within 30 days. Women had higher odds of being readmitted within 30 days
compared to men. There was no statistically significant relationship between primary
payer status and 30-day readmission rates among individuals whose primary or secondary
reason for admission was T2DM. Sociodemographic factors such as age, gender, or
income did not moderate the relationship between primary payer status and 30-day
hospital readmission rates nationally. The study contributes to positive social change by
providing hospital administrators with knowledge they can use to implement protocols
prior to discharge that may prevent possible readmissions, potentially reducing costs to
facilities and improving patient care.
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Section 1: Foundation of the Study and Literature Review
Introduction
Hospital readmission within 30 days of discharge is a significant aspect of health
care reform in the United States. The focus of healthcare systems and governmental
agencies is to identify ways to improve the quality of healthcare, with a special
concentration on reducing 30-day readmission rates (Ostlling et al., 2017). Reducing
readmissions gives hospitals a financial incentive to make discharge communication and
care coordination efforts seamless for patients and caregivers (VanLare & Conway,
2012).
Thirty-day readmissions have become an important measure of quality care and a
target for reducing healthcare costs (Rubin, McDonnell, Golden, & Zhao, 2017).
Following implementation of the Patient Protection and Affordable Care Act of 2010, the
Centers for Medicare and Medicaid Services (CMS) began the Hospital Readmission
Reduction Program (HRRP; Ostlling et al., 2017). The HRRP is composed of five
specific measures to determine reimbursement rates for hospital readmissions; these
measures include pneumonia, heart failure, chronic obstructive pulmonary disease
exacerbation (COPD), acute myocardial infarction, and total hip/knee replacement
(Ostlling et al., 2017).
A facility’s 30-day readmission rate is based on all unplanned readmissions that
occur within 30 days of discharge, regardless of the cause. The risk index includes
patients who are readmitted to the same hospital or another acute care hospital for any
reason, regardless of their primary diagnosis. The measures do not include planned
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readmissions. Currently, CMS measures hospital performance in the HRRP by
calculating excess readmission ratios (ERRs) for each of the program measures. A
hospital’s ERR is the ratio of predicted-to-expected readmissions for a given measure
(CMS, 2017). Hospitals with high ERRs are subject to a financial penalty; in 2015 alone,
more than 2,600 U.S. hospitals received reimbursement reductions from CMS because of
high readmission ratios (Chakraborty et al., 2017). Accordingly, 30-day readmission rates
have become an important metric for care quality in hospitals in the United States
(Chakraborty et al., 2017), as well as a focus of hospital administrators charged with
improving the financial viability of acute care facilities.
Diabetes is a leading cause of hospitalization and readmission in the United States
(Donze, Lipsitz, Bates, & Schnipper, 2013), and it creates significant burdens to patients,
healthcare providers, and the economy (McCoy et al., 2017). This disease affects an
estimated 23.6 million Americans and is the seventh leading cause of death in the United
States (Kim, Ross, Melkus, Zhao, & Boockvar, 2010). The prevalence of diabetes
increases each year (Hicks et al., 2016). An estimated 9.3% of the United States’
population was diabetic in 2012 (Centers for Disease Control and Prevention, 2017).
Experts estimated that 28% of individuals with diabetes are undiagnosed (Ostlling et al.,
2017). The estimated direct costs spent on diabetes in 2012 were $176 billion dollars;
healthcare costs for individuals with diabetes were 2.3 times higher than for those without
the disease (American Diabetes Association [ADA], 2013; Kim et al., 2010). Hospital
care accounts for over half of the healthcare expenditures associated with diabetes (ADA,
2008).
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Diabetic patients are susceptible to a host of comorbidities such as congestive
heart failure (McCoy et al., 2017), neuropathy, retinopathy, stroke, and nephropathy
(Fowler, 2008). The high incidence of comorbidities associated with diabetes contributes
to a high 30-day readmission rate among these patients (Ostlling et al., 2017; Raval et al.,
2015), which some studies indicate was as high as 22.7% (Burke & Coleman, 2013;
Jiang, Stryer, Friedman, & Andrews, 2003; Robbins & Webb, 2006). The costs
associated with 30-day readmissions among diabetic patients are substantial; the
Medicare Payment Advisory Commission (MedPAC) estimated that 30-day readmissions
accounted for annual care spending of $15 billion dollars (Raval et al., 2015). A large
portion of those costs may also be preventable. Kim et al. (2010) reported that nearly one
fifth of readmissions could have been prevented, which would have resulted in healthcare
savings of $72.7 million dollars.
A number of other factors also contribute to high readmission rates among
diabetic patients such as longer length of stay (McCoy et al., 2017), male sex (Robbins &
Webb, 2006; Rubin et al., 2017; Zapatero et al., 2014), minority race (Basu, Hanchate, &
Bierman, 2018; Kim et al., 2010; Robbins & Webb, 2006), and low socioeconomic status
(Kim et al., 2010). Another important predictor of 30-day readmission is insurance status,
which includes being uninsured or having Medicaid, Medicare, or private insurance
(Friedman, Jiang, & Elixhauser, 2008; Robbins & Webb, 2006; Rubin et al., 2017). For
example, Rubin et al. (2017) found that diabetic patients with Medicare and Medicaid
were significantly more likely to experience a 30-day readmission than were patients with
private insurance or those who were uninsured. Similarly, Robbins and Webb (2006)
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found that the likelihood of readmission among diabetic patients with private insurance or
no insurance was 34.5% and 32.2% lower, respectively, than that of diabetic Medicare
patients. Kim et al. (2010) also found that patients with Medicare or Medicaid were more
likely to experience readmission than patients with private insurance.
A more general study on readmissions conducted by Basu et al. (2018) revealed
that uninsured patients had the lowest readmission rates of all payer groups and that
publicly insured patients were the most likely to experience readmission. Among the
publicly insured, Basu et al. found that Medicare patients were more likely to experience
readmission than were patients with Medicaid. Findings from Chakraborty’s (2017) study
echoed those from Basu et al. regarding the high readmission rates among Medicare
patients across all payer groups.
Robbins and Webb (2006) posited that higher rates of readmission among
Medicare and Medicaid patients relative to those with private insurance are reflective of
socioeconomic factors associated with insurance status. Basu et al. (2018) pointed to
research that indicated insurance status is associated with aspects of postacute care,
which correlates with readmission rates. For example, those without insurance may lack
access to follow-up care, and care decisions for patients with public insurance are often
driven by financial incentives (Cai, Miller, Nelson, & Mukamel, 2015). Other researchers
have reported similar trends regarding the influence of insurance status on care outcomes
(Englum et al., 2016). Basu et al. posited that the phenomenon was the result of the lack
of insurance coverage and poor access to care, particularly among minorities. Lower rates
of readmission cannot always be assumed to be a positive indicator of care outcomes
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(Basu et al., 2018). In addition, the influence of insurance payer status on readmissions
among diabetic patients is not quite clear as few researchers have examined this issue
across all payer status types.
Applying general interventions across patient populations is cost-prohibitive;
thus, it is important to identify patients at the greatest risk of 30-day readmission in order
to more efficiently utilize care resources (Rubin et al., 2017). Insurance payer status is
likely to be a risk factor, although methodological limitations have made findings from
previous research somewhat conflicting. Readmission rates may be the result of
differences in patient characteristics (Basu et al., 2018; Carey & Lin, 2015; Singh, Lin,
Kuo, Nattinger, & Goodwin, 2014). That is, patients’ demographic characteristics may
moderate the relationships between insurance payer status and readmission rates.
This study was unique because it involved an examination of the relationship
between four insurance payer statuses (Medicare, Medicaid, private insurance, and
uninsured) and 30-day readmission rates among individuals whose primary or secondary
reason for admission was Type 2 diabetes mellitus (T2DM). A significant proportion of
the immense costs associated with diabetes care are attributed to hospitalization and
readmissions (ADA, 2008; Raval et al., 2015). Much of the existing research on 30-day
readmission of diabetic patients focuses on Medicare (Chakraborty et al., 2017). The
findings of this study may inform health care policy makers and healthcare providers
regarding the readmission rates grouped by diabetic subpopulations at the greatest risk for
readmission. The potential clarification provided by the study is important because
interventions aimed at reducing the 30-day readmission rates of diabetic patients are
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resource intensive (Hansen, Young, Hinami, Leung, & Williams, 2011; Rubin et al.,
2017).
In this section, I will provide an introduction to the study along with background
information required to conceptualize the research and expose the gap that was addressed
in this study. The problem, purpose, research questions and hypotheses, and conceptual
framework will be presented, followed by discussion of the study’s nature and a review
of relevant literature. Key terms, assumptions, and delimitations will also be presented.
The section closes with discussion of the study’s social significance, a summary and
conclusion, and a transition to Section 2.
Problem Statement
Approximately 30.3 million people in the United States have diabetes mellitus
(DM), which is a modern epidemic (Centers for Disease Control and Prevention [CDC],
2017). In 2015, diabetes was the seventh leading cause of death in the United States
(CDC, 2017). Of all patients who are hospitalized or readmitted, 25% were noted as
having diabetes or an associated comorbidity (Zakowski, 2017). Patients with DM have
higher acute care hospital readmission rates than non-DM patients (Drincic, Pfeffer, Luo,
& Goldner, 2017). Diabetic patients have more underlying comorbidities than patients
without the disease including hypertension, renal failure, diabetic neuropathy, and
diabetic retinopathy (Moses, Mawby, & Phillips, 2013). These comorbidities may result
in increased health care spending, elevated hospital readmission rates, and reduced
quality of life (Schram et al., 2014).
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According to MedPac, approximately 20% of Medicare patients who are
discharged from hospitals are readmitted within 30 days (Mcllvennan, Eapen, & Allen,
2015). Hospital readmissions have become a dangerous and regular occurrence, placing
an enormous monetary burden on the United States’ health care system (Stefan et al.,
2012.). Reducing preventable readmissions by just 10% could reduce Medicare
expenditures by $1 billion dollars annually (Raval et al., 2015). More than half of
hospital readmissions are preventable (Miller & Washington, 2012), including those for
diabetic patients. In order to prevent readmissions among diabetic patients most employ
targeted interventions must be employed among patient subpopulations at the greatest
risk for readmission. A known predictor of readmission is insurance status (Rubin,
McDonnell, Golden, & Zhoa, 2017); however, a gap in the literature exists regarding
differences in 30-day readmission rates across different insurance payer groups for
individuals whose primary or secondary cause for remission is T2DM. According to my
research, little is known regarding whether and how sociodemographic factors, such as
race, education level, or marital status, moderate the relationship between insurance
primary payer status and readmission rates among individuals whose primary or
secondary reason for readmission is T2DM.
More research is needed to better understand the factors that place diabetic
patients at the greatest risk for readmission. Insurance status may affect rates of 30-day
readmission, for diabetic patients (Friedman et al., 2008; Robbins & Webb, 2006; Rubin
et al., 2017), yet much of the existing literature focused on Medicare recipients or
includes all payer groups together (Chakraborty et al., 2017). Jiang et al. (2005) argued
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that examining 30-day readmission rates across individual payer groups may be useful for
identifying and targeting interventions for the diabetic subpopulations at the greatest risk
for readmission.
Purpose of the Study
The purpose of this quantitative, correlational study was to use secondary data to
examine the relationship between primary payer status (Medicare, Medicaid, uninsured,
or private insurance) and hospital readmission rates among individuals whose primary or
secondary reason for admission was T2DM. In addition, I analyzed whether
sociodemographic factors (age, gender, and income) moderate the relationship between
primary payer status (Medicare, Medicaid, uninsured, or private insurance) and hospital
readmission rates among individuals whose primary or secondary reason for admission
was T2DM. Four independent variables (Medicare, Medicaid, uninsured, or private
insurance) were included in the primary payer status. The dependent variable was
hospital readmission rate. Three additional variables (age, gender, and income) were
tested for moderation. I gathered data from the 2015 Healthcare Cost and Utilization
Project (HCUP) Nationwide Readmission Database (NRD). The scope of the study was
the United States as a nation, where 9.4% of the population has diabetes, and several
hundred thousand others are prediabetic (Centers for Disease Control and Prevention,
2017). Findings from the study may inform health care providers about a possible
correlation between DM patients’ rate of readmission and insurance payer status.
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Research Question and Hypotheses
Following are the research questions (RQs) and hypotheses for the study. The
RQs are also illustrated in Figures 1 and 2.
RQ1. What is the relationship, if any, between primary payer status (Medicare,
Medicaid, uninsured, or private insurance) and 30-day readmission rates among
individuals whose primary or secondary reason for admission was T2DM nationally?
Figure 1 illustrates RQ1.
H01. No statistically significant relationship exists between primary payer status
(Medicare, Medicaid, uninsured, or private insurance) and 30-day readmission rates
among individuals whose primary or secondary reason for admission was T2DM
nationally.
HA1. A statistically significant relationship exists between primary payer status
(Medicare, Medicaid, uninsured, or private insurance) and 30-day readmission rates
among individuals whose primary or secondary reason for admission was T2DM
nationally.
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Medicaid
(IV)

Medicare
(IV)
Private
Insurance
(IV)

30-day
Readmission
Rate (DV)

Uninsured
(IV)

Figure 1. Model for Research Question 1.

RQ2. Do sociodemographic factors like age, gender, and income moderate the
relationship between primary payer status (Medicare, Medicaid, uninsured, or private
insurance) and 30-day readmission rates among individuals whose primary or secondary
reason for admission was T2DM nationally? Figure 2 illustrates RQ2.
H02. Sociodemographic factors like age, gender, and income do not moderate the
relationship between primary payer status (Medicare, Medicaid, uninsured, or private
insurance) and hospital 30-day rates among individuals whose primary or secondary
reason for admission was T2DM nationally.
HA2. Sociodemographic factors like age, gender, and income moderate the
relationship between primary payer status (Medicare, Medicaid, uninsured, or private
insurance) and 30-day readmission rates among individuals whose primary or secondary
reason for admission was T2DM nationally.
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Medicaid
(IV)

Age (mod)
Medicare
(IV)
Gender (mod)
Private
Insurance
(IV)

30-Day
Readmission
Rate (DV)

Income (mod)

Uninsured
(IV)

Figure 2. Model for Research Question 2.

Conceptual Framework
The conceptual framework of the study was the Donabedian framework, which is
a conceptual model for examining health services and evaluating the quality of healthcare
(Sund, Iwarsson, & Brandt, 2015). This framework was developed by Avedis
Donabedian, a professor at the University of Michigan School of Public Health and one
of the leaders commissioned to review the quality of public health following enactment
of the Medicare and Medicaid programs in 1965 (Ayanian & Markel, 2016). The
Donabedian framework uses information from three categories to determine the quality
of care including structure, process, and outcome. Structure refers to the method by
which care is delivered. Structural factors may include, but are not limited to, the
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hospital’s facility, qualifications of care providers, human resources, accounting, and
material resources (Sund et al., 2015). Process entails the transactions between patients
and providers during the delivery of healthcare, and it includes the components of care
delivered to patients (Ayanian & Markel, 2016). Outcome describes the effect of
healthcare on the health status of patients and populations such as recovery, survival, and
restoration of health (Ayanian & Markel, 2016; Sund et al., 2015).
The Donabedian framework provided an important foundation for examining the
relationships between insurance primary payer’s status, demographic characteristics, and
30-day readmission rates among patients with T2DM. In the context of this investigation,
factors related to Donabedian’s definitions of structure and outcomes were examined.
Insurance coverage and payer status are structural factors, while 30-day readmission rates
are outcomes. Hyder et al. (2013) used the framework to discuss hospital, physician, and
patient-level factors that influenced 30-day readmissions among pancreatoduodenectomy
patients. Moore, Lavoie, Bourgeois, and Lapointe (2015) employed the framework to
examine trauma care outcomes including readmissions. McHugh and Ma (2013) used
Donabedian’s framework to explore 30-day readmissions among Medicare patients with
pneumonia, heart failure, and acute myocardial infarction. In diabetes research, Miles
(2019) used the framework to assess diabetics’ knowledge of care management as a
strategy to improve care transition and reduce readmissions.
Nature of the Study
The nature of the study was quantitative, and it followed a cross-sectional,
correlational design. The population of focus consisted of patients who experienced 30-
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day readmissions to hospitals nationally in 2013 to 2015 for a primary or secondary
reason of T2DM. The researcher conducted multiple linear regression to assess for a
correlation between the independent variables of primary payer status (Medicare,
Medicaid, uninsured, or private insurance) and the dependent variable of hospital
readmission rate.
Although some researchers combine Medicaid and Medicare recipients, or
Medicaid and uninsured patients, Robbins and Webb (2006) cautioned that this exercise
ought to be evaded except if the two groups are found to have comparative dangers in the
data. The majority of literature on hospital readmission rates is based on Medicare data;
much less is known about differences in readmission risks across insurance payer groups
(Chakraborty et al., 2017). Accordingly, the study involved an examination of each of
these groups separately. Payer status is an indicator of a patient’s socioeconomic status
and an impression of the extraordinary segment and clinical attributes of every
subpopulation (Jiang et al., 2005). In addition, each payer has unique financing
mechanisms, provider networks, and models of delivery (Jiang et al., 2005), so it is
important to examine payer status, separately. By examining 30-day readmission rates
associated with each payer status, and understanding how demographic characteristics
may moderate these relationships, policymakers and healthcare providers may use
findings to more efficiently target subpopulations at risk for readmission (Jiang et al.,
2005).
For the second RQ, demographic characteristics, age, gender, and income were
examined as potential moderators in the relationships between primary insurance payer
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status and hospital readmission rates. A multivariable analysis allowed the researcher to
examine the relationships between the dependent and independent variables. Findings
may shed light on differences in readmission rates among T2DM patients based on
primary payer status, and how patient characteristics may moderate those relationships.
Literature Review
This section includes a review of the existing research on diabetes, hospital
readmissions, and the influence of insurance coverage on care outcomes such as
readmission rates. Topics in this review include 30-day readmission rates in United
States’ hospitals, Medicare history, incidence of diabetes in the United States, costs of
diabetes, diabetes and 30-day readmission rates, Medicare spending on diabetes,
readmission risk index for diabetic patients, socioeconomic status and readmission,
insurance coverage and 30-day readmission rates, and care discrepancies by insurance
status.
Literature Search Strategy
The intention of the research study was to examine the relationship between
insurance primary payer status (Medicare, Medicaid, uninsured, or private insurance) and
hospital readmission rates among individuals whose primary or secondary reason for
admission was T2DM. In addition, the researcher examined if sociodemographic factors
(age, gender, income) moderate the relationship between insurance primary payer status
and hospital readmission rates among these patients. In order to contextualize the study
and provide adequate background information, an exhaustive review of the literature was
performed. Relevant peer-reviewed sources were gathered from a number of online
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databases, including Medline, EBSCOhost, government reports, Cochrane, PubMed,
BioMed Central, Google Scholar, and Cumulative Index to Nursing and Allied Health
Literature (CINAHL). Additional relevant resources included databases provided by the
Centers for Medicare & Medicaid (CMS) and the National Institute of Health (NIH). The
researcher endeavored to include recent scholarship published within the last 5 years.
Older studies that were relevant or seminal were included as appropriate. Table 1
provides a summary of search terms employed, the number of corresponding results, and
the total resources used for each.
Table 1
Summary of Literature Review Keywords/ Boolean Phrase Search Terms
Keyword/Boolean phrase
Affordable Care Act and 30 readmission
rate
Medicare spending on diabetes
Medicare spending in the state of Georgia
on diabetes
30-day readmission rate for Medicare
diabetic patients
30-day readmission rate and Medicare
spending for diabetic patients
ICD 10 code for diabetes
How is Medicare funded
CMS and diabetes
Studies on diabetes and hospital 30-day
readmission rates

Google Scholar search engine Resources
results
18,000
4
17,000
14,100

12
7

16,100

12

17,800

12

19,200
24,500
21,800
17,700

3
4
2
6

A matrix of the selected literature is provided in Appendix. This matrix highlights
the following characteristics of each study: authors, population, variables, study type, and
outcomes. Overall, findings from the matrix revealed the gap in research regarding the
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ways primary payer status and sociodemographic factors may influence readmission rates
among individuals with T2DM. This literature review expands on the information
included in the matrix by revealing the research gap and contextualizing the study.
30-Day Readmission Rates in United States’ Hospitals
Thirty-day readmissions have become an important measure of care quality and
target for reducing healthcare costs (Rubin et al., 2017). Following implementation of the
Affordable Care Act, the Center for Medicare and Medicaid Services (CMS) began
utilizing a Hospital Readmission Reduction Program (HRRP), which was part of the
Patient Protection and Affordable Care Act (Ostlling et al., 2017). The HRRP is
composed of five specific measures to determine reimbursement rates for hospital
readmissions which include pneumonia, heart failure, chronic obstructive pulmonary
disease exacerbation (COPD), acute myocardial infarction, and total hip/knee
replacement (Ostlling et al., 2017).
The 30-day readmission measures include all unplanned readmissions that occur
within 30 days of discharge, regardless of the cause. The risk index includes patients who
are readmitted to the same hospital or another acute care hospital for any reason,
regardless of their primary diagnosis. The measures do not include planned readmissions.
Currently, CMS measures hospital performance in the HRRP by calculating excess
readmission ratios (ERR) for each of the program measures. A hospital’s ERR is the ratio
of predicted-to-expected readmissions for a given measure (Centers for Medicare and
Medicaid Services, 2017). Hospitals with high ERRs are subject to financial penalty; in
2015, more than 2,600 hospitals received reimbursement reductions from CMS because
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of high readmission ratios (Chakraborty et al., 2017). Accordingly, 30-day readmission
rates have become an important metric for care quality in United States’ hospitals
(Chakraborty et al., 2017), as well as a focus of leaders charged with improving the
financial viability of acute care facilities. Many local, state, and national campaigns have
emerged to help reduce readmission rates (Bradley et al., 2013).
Despite increase attention to the issues of readmission, evidence regarding the
best strategies for reducing readmissions is still limited (Bradley et al., 2013). In
controlled trials, readmission interventions focus on follow-up and nurse staffing
demonstrated success (Coleman, Parry, Chalmers, & Min, 2006). Bradley et al. (2013)
pointed out less is known about the effectiveness of such interventions outside of
controlled trials. Large variation exists in the strategies used by hospitals to reduce
readmission (Bradley et al., 2012; House, Stephens, Whiteman, Biearman, & Printz,
2016).
Medicare History
The topic of 30-day readmission has received growing attention since CMS began
to penalize acute care facilities that demonstrate high rates of readmission among
Medicare and Medicaid patients by reducing reimbursements. Medicare is a federal
health insurance program that was formed in 1965 by President Lyndon B. Johnson
(Tierney, 2013). The Medicare Program is the second-largest social insurance program in
the United States (CMS, 2013). The initial purpose of the Medicare program was to
provide medical insurance to individuals who were 65 years of age or older (Oberlander,
2019). In 1972, President Nixon expanded the Medicare program to include individuals
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with end-stage renal disease and acute disabilities (Tierney, 2013). Medicare spending is
mainly controlled and regulated by the federal government (McHugh & Ma, 2013).
Medicare is paid through the Hospital Insurance Trust Fund (HI) and the Supplemental
Insurance Trust (Tierney, 2013).
The HI trust is funded through payroll taxes, income taxes, and Medicare Part A
premiums (Tierney, 2013). These HI funds are managed by a board of trustees that
provides annual reports to Congress on the financial status of the plan. The soundness of
the HI trust fund is one of the measurements of Medicare’s financial status (Davis et al.,
2017). Since the sole concentration of the HI trust fund is the status of Medicare Part A, it
does not portray a thorough analysis of the program expenditures (Davis et al., 2017).
During years when annual income to the trust fund exceeds benefits spending, the asset
level increases; when yearly spending exceeds revenues, the asset level decreases (Davis,
et al., 2017). Although the HI trust fund was expected to become insolvent, government
regulations and changes have sustained it. The latest legislative changes suggest the HI
trust fund will become bankrupt by the year 2026, barring any further governmental
regulations (Davis et al., 2017).
The Supplemental Insurance Trust Fund, which includes Medicare Part B and Part
D, is funded through premiums of Medicare recipients (Davis et al., 2017). Part B covers
outpatient services, home health, and preventive care services (Davis et al., 2017). Part D
offers voluntary Medicare prescription drug benefits for recipients through private
insurance plans (Shrank & Polinski, 2015). When Medicare Part D was implemented in
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2006, it was the most significant expansion to Medicare since its inception in 1965
(Shrank & Polinski, 2015).
The number of individuals enrolled in Medicare is substantial. It was reported that
in 2013, there were over 40 million beneficiaries in the United States and by 2030 this
number will increase to about 84 million (MedPAC, 2017). As the baby boomer
generation ages out of the workforce, the burden to support Medicare will rise as
contributors decrease. According to MedPAC (MedPAC, 2017), “the number of
taxpaying workers per Medicare beneficiary has declined form 4.6 during the early years
of the program to 3; by 2029, this number is projected by the Medicare Trustees to be
2.4” (p. 16). These figures help to illustrate how increasingly burdened the Medicare
program will continue to become, and why the costs of hospital readmissions receive
growing attention from leaders and policymakers.
Prevalence of Diabetes in the United States
A major contributor to the readmission rate among individuals with Medicare and
Medicaid is diabetes (Rubin et al., 2017). Diabetes affects an estimated 23.6 million
Americans, and it is the seventh leading cause of death (Kim et al., 2010). The prevalence
of the disease is steadily rising (Hicks et al., 2016). Ostlling et al. (2017), and it has been
estimated that 9.3% of the United States’ population is diabetic, 28% of which is
undiagnosed. A comprehensive estimate of the prevalence of diabetes in the United
States conducted by Menke, Casagrande, Geiss, and Cowie, (2015) revealed the
prevalence rate was even higher. Using cross-sectional survey data, Menke et al. (2015)
reported that the unadjusted prevalence of diabetes was 14.3% with over 25% of those
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cases undiagnosed. The rate of the disease is higher among non-Hispanic Blacks (21.8%),
non-Hispanic Asians (20.6%), and Hispanics (22.6%) (Menke et al., 2015).
The increasing prevalence of diabetes aligns well with the increasing prevalence
of obesity among the United States’ population (Menke et al., 2014). As explained by the
NCD Risk Factor Collaboration (2015), the incidences of diabetes and diabetes-related
mortality have increased throughout the world, largely fueled by global increases in being
overweight and obese. The upward trend in diabetes created significant consequences for
individuals and health care systems (Zimmet, Magliano, Herman, & Shaw, 2014). The
prevalence of T2DM is highest among the elderly, minorities (non-Hispanic American
Indian, non-Hispanic Blacks, and Hispanics), and slightly more common in men than
women (Bullard et al., 2018).
Cost of Diabetes
The costs of the increasing prevalence of diabetes in the United States are
substantial. The estimated direct costs spent on diabetes in 2012 were $176 billion dollars
(ADA, 2013); healthcare costs for individuals with diabetes are 2.3 times higher than for
those without the disease (Kim et al., 2010). Hospital care accounts for over half of the
healthcare expenditures associated with diabetes (ADA, 2008), which are not just related
to enormous healthcare expenses, but also the loss of productivity among those sick with
the disease. Menke et al. (2015) estimated the total costs in care and lost productivity
associated with diabetes to be $245 billion dollars annually, while Bullard et al. (2018)
estimated total costs of diabetes to be $327 billion dollars.
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Diabetes and 30-Day Readmission Rates
A large proportion of the healthcare costs associated with diabetes is attributed to
hospital readmissions. Diabetic patients are susceptible to a host of comorbidities such as
congestive heart failure (McCoy et al., 2017), neuropathy, retinopathy, stroke, and
nephropathy (Fowler, 2011). Co-morbidities associated with diabetes correlate to the
22.7% 30-day readmission rate among these patients at a substantial cost (Burke &
Coleman, 2013; Ostlling et al., 2017; Raval et al., 2015). The 30-day all-cause
readmission rate is 13.9% (Fingar, Barrett, & Jiang, 2017), indicating that readmission
rates specific to diabetes are significantly higher. Robbins and Webb (2006), in a
germinal study, found that when diabetes was a primary diagnosis, the 30-day
readmission rate was 9.4% but if a diabetic patient was admitted for another reason and
diabetes was not listed as a secondary diagnosis, the 30-day readmission rate was 30.6%.
For example, Medpac estimated that all-cause 30-day readmissions accounted for annual
care spending of $15 billion dollars (Raval et al., 2015). Kim et al. (2010) estimated that
nearly one-fifth of readmissions may have been prevented, which would have resulted in
healthcare savings of $72.7 million dollars. The potential for reducing readmissions is of
interest to policymakers and healthcare leaders and is a target of the study.
Insurance Coverage and 30-Day Readmission Rates
In addition to high rates of comorbidities, several research studies indicate that a
number of other factors contribute the high readmission risk among diabetic patients.
These factors include hospital length of stay, male gender, minority race, and low
socioeconomic status (Basu et al., 2018; Kim et al., 2010; McCoy et al., 2017; Rubin et
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al., 2017; Zapatero et al., 2014). An important predictor of 30-day readmissions may be
insurance status and type, Medicaid, Medicare, private insurance, or uninsured (Friedman
et al., 2008; Robbins & Webb, 2006; Rubin et al., 2017). Rubin et al. (2017) found that
diabetic patients with Medicare and Medicaid were more likely to experience a 30-day
readmission than patients with private insurance or those who were uninsured. Rubin et
al. reported 30-day readmission rates for Medicare and Medicaid recipients were 45.6%
and 11.6%, respectively. Everett and Mathioudakis (2019) found that insurance status
was the strongest predictor of readmission among diabetic ketoacidosis patients.
In a study of socioeconomic, clinical, and demographic factors associated with
readmissions among diabetic patients, Kim et al. (2010) found that patients with
Medicare or Medicaid were more likely to experience readmission than patients with
private insurance. Hicks et al.’s (2016) study on the costs of foot ulcers among diabetic
patients revealed that over three-quarters of hospitalized patients had Medicare or
Medicaid. A more general study on readmissions conducted by Basu et al. (2018)
revealed that uninsured patients had the lowest readmission rates of all payer groups, and
publicly insured patients were the most likely to experience readmission. Among the
publicly insured, Basu et al. found that Medicare patients were more likely to experience
readmission than patients with Medicaid. Findings from Chakraborty’s (2017) study
echoed those from Basu et al. regarding the highest readmission rates among Medicare
patients across all payer groups.
Robbins and Webb (2006) posited that higher rates of rehospitalization among
Medicare and Medicaid patients relative to those with private insurance is likely to reflect
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socioeconomic factors associated with insurance status. Basu et al. (2018) indicated
insurance status is associated with aspects of post-acute care which correlates with
readmission rates. For example, those without insurance may lack access to follow-up
care, and care decisions for patients with public insurance are often driven by financial
incentives (Cai et al., 2015). Other researchers have reported similar trends regarding the
influence of insurance status on care outcomes (Chakraborty, et al., 2017; Englum, et al.,
2016). For example, Englum et al. (2016) examined the relationship between hospital
status and length of stay among trauma patients and found that uninsured patients had a
significantly shorter length of stay than patients with private insurance. Publicly insured
patients in Englum et al.’s study had the longest length of stay; however, this does not
necessarily indicate that publicly insured patients received the best care. In fact,
researchers reported that longer lengths of stay are associated with higher risks for 30-day
readmission (Chakraborty et al., 2017).
Medicare Spending on Patients with Diabetes Mellitus
Medicare spending is estimated to grow to about $171 billion dollars by the year
2034 (Raval, et al., 2015). Diabetic patients are hospitalized frequently (Raval et al.,
2015). The program currently spends about 32% of its budget on diabetes and associated
comorbidities (Silveira et al., 2018). According to Erkan Erdem (2014), the average
annual Medicare spending on diabetes patients with Part A and Part B Medicare is $5,741
to $5,991 dollars.
Hospital readmissions are linked to poor patient outcomes and increased monetary
expenditures (Mcllvennan et al., 2015). Approximately 25% of all hospitalized patients
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have DM (Ostlling, et al., 2017) The direct medical costs of DM were $176 billion
dollars in 2012, 43% of which was spent on direct inpatient care (Ostlling et al., 2017).
Many factors contribute to hospital readmission within 30-days of discharge. For
example, diabetes care increases the use of health care services, medications, and medical
supplies (Mcllvennan et al., 2015). Medicare patients comprise almost 20% of 30-day
hospital readmissions (Mcllvennan et al., 2015).
Over 21 million medical doctor office visits annually are scheduled for diabetes.
An estimated one-third of Medicare expenditures are related to diabetes (Dugan &
Shubrook, 2017). Coding for diabetes must be accurate to ensure that the providers and
institutions receive the proper reimbursement rate. In accordance with ICD-10 guidelines,
coding for diabetes requires four or five digits, for accuracy. The coding identifies the
type of diabetes, patient’s current diabetic status (i.e. Type 1, Type 2, or gestational
diabetes), and comorbidities of the disease (Dugan & Shubrook, 2017).
In 2010, under the Affordable Care Act, the federal government instituted two
programs aimed at reducing 30-day hospital readmissions. These programs included the
Hospital Readmissions Reduction Program (HRRP) and the Bundled Payments for Care
Improvement Initiative (BPCI) (Carey & Stefos, 2016). The HRRP is the most developed
mandatory incentive of the CMS program and has the largest monetary impact on
hospitals across the country (Ryan, Adler-Milstein, Damberg, Maurer, & Hollingsworth,
2017). Under the HRRP, CMS reduces payments to inpatient prospective payment
systems (IPPS) hospitals with excessive readmission rates (Carey & Stefos, 2016). The
first penalties affecting the payments were for discharges beginning in October, 2012.
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During the 2013 fiscal year, CMS began imposing a payment reduction of up to 1% to
hospitals that exceeded expected readmission rates for acute myocardial infarction
(AMI), heart failure, and pneumonia (Ryan et al., 2017). By the 2015 fiscal year, the
payment reduction increased to 3% (Ryan et al., 2017).
The BPCI was an initiative developed by CMS to improve care by bundling
payments for beneficiaries of multiple services for single care episodes (Andrawis,
Koenig, & Bozic, 2016). Under the BPCI, healthcare facilities enter payment agreements
that stipulate financial and performance accountability for care episodes. The goal of the
BPCI is to improve care quality and coordination while lowering Medicare costs
(Andrawis, Koenig, & Bozic, 2016).
Medicare’s prospective payment system (PPS) was introduced in 1983. Under this
system, hospitals are paid a fixed rate per admission diagnosis (Krinsky, Ryan,
Mijanovich, & Blustein, 2017). A primary component of PPS is the diagnosis-related
groups (DRGs), which consist of medical and surgical services (Bowman, 2016). The
World Health Organization adopted the International Classification of Disease, ICD-10
revision in 2004, which is the international standard (Bowman, 2016). The ICD-10
replaced the ICD-9, which lacked detail expected to precisely reflect current clinical
phrasing and methods and can't be extended further to remember new revelations and
methodology for medication (Coutasse & Paul, 2013). The United States did not
officially mandate the implementation of the ICD-10 until October 2015 (Bowman,
2016). Although the CMS originally mandated the transition to ICD-10 codes by 2011,
the transition was twice delayed due to financial and administrative concerns expressed
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by care providers regarding their ability to comply with the transition deadlines. The
DRGs categorize all human ailments according to the body part that is affected by the
illness, the sex of the patient, and morbidity (Bowman, 2016). Eight diagnoses are
accounted for in the classification and up to six procedures during the hospital stay
(Bowman, 2016).
Readmission Rate for Medicare Patients with Diabetes
A systematic review by Raval et al. (2015) utilized a nationwide database of
Medicare recipients to estimate the frequency of 30-day readmission rates among elderly
Medicare beneficiaries with T2DM. The study followed a retrospective longitudinal
cohort design. The timeframe of the study was between January 2007 and August 2011.
The study population consisted of 12 million Humana Medicare Advantage part D
recipients who (a) had a primary or secondary diagnosis of T2DM; (b) were 65 years of
age and older; and (c) were enrolled in the plan between January 2007 and April 2012.
Participants were enrolled in the plan six months before admission and 30 days after
hospital discharge. The dependent variable of the study was readmission rate. Recipients
were categorized into two groups: (a) recipients who were re-admitted within 30 days;
and (b) recipients with no readmission with 30 days.
The independent variables in Raval et al.’s (2015) study included length of stay,
sex, age, secondary diagnosis diabetes, and primary diagnosis diabetes. The results of the
study were consistent with similar studies on patient 30-day readmission rates for T2DM,
in which patient-level stressors of overall poor health conditions that are specifically
related to the elderly population (such as cognitive impairment, falls, and fall risks) were
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the most commonly identified risk factors for readmission. These findings may have
implications for reducing the 30-day hospital readmission rate through effective post-care
planning before discharge.
Sonmez, Kambo, Avtanksi, Lutsky, and Poretsky (2017) conducted a
retrospective cohort study of 102,694 patients who were admitted to an urban teaching
hospital between January 1, 2013 and September 30, 2015. The primary or secondary
admitting diagnosis had to be diabetes in order for the patient to be included in the study.
The number of patients with a primary or secondary admitting diagnosis of diabetes was
16,266. The researchers compared 30-day hospital readmission rates for patients with
diabetes to those without the disease. The researchers also examined the connections
between the length of stay (LOS) for patients with diabetes and the length of stay for
patients without diabetes. The data source was the hospital billing system. The dependent
variables were readmission rate with or without diabetes. The independent variables were
length of stay, gender, age, secondary diabetes, and primary diabetes.
The results of Somez et al.’s (2017) study revealed that diabetic patients were
2.47 times more likely to be readmitted than patients without diabetes. Patients 65 years
of age and older were more likely to be readmitted within 30 days than patients between
the ages of 18 and 64. The researchers also found that male diabetic patients were more
likely to be readmitted than female patients. A major limitation of this study is that it was
conducted at a single urban hospital, and other area hospitals were not included in the
study. As a result of the study being retrospective, there may have been bias in the patient
selection process, data accuracy, and patient follow-up. The data from the hospital billing
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system did not include clinical information about patients’ medical conditions which may
have impacted the LOS or readmission rates.
A cross sectional study conducted by Alavi, Baharlooei, and AdelMehraban
(2017) revealed that despite the advances in diabetic care and treatment, elderly patients
still had high rates of hospital readmissions. The primary goal of the study was to
examine the psychosocial factors that may contribute to the readmission rate of elderly
diabetic patients. The researchers concluded that developing social support services may
help in the reduction of readmission rate for this population while also improving the
mental health status of the elderly. However, the researchers recommended further
research on ways to decrease depression, anxiety, and stress among the elderly.
Readmission Risk Index for Diabetic Patients
The Diabetes Early Readmission Risk Index (DERRITM) is a multivariable
logistic regression model tool that predicts all-cause 30-day readmission risks for
patients who are hospitalized with diabetes (Rubin, 2018). Persons with diabetes account
for about 20% of hospitalizations annually (Rubin et al., 2017). Diabetic patients with
cardiovascular disease (CVD) comprise 25% to 30% of the hospital admissions for this
subgroup (Rubin et al., 2017). Rubin et al. (2017) simulated the tool and added
cardiovascular disease to the tool in a retrospective cohort study. The tool was called the
Diabetes Early Readmission Risk Indicator for cardiovascular disease (DERRI-CVDTM).
The aim of the study was to compare the performance of the DERRITM to the DERRICVDTM. The study consisted of 8,189 discharges between January 1, 2004, and
December 31, 2012, which were selected from the electronic medical records system of
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Boston Medical center. The cohort was the same one that was used for the DERRI TM.
However, the DERRI TM did not have the stipulation of having a primary diagnosis of
CVD. The primary purpose of the study was to invent a functional tool that would predict
the 30-day readmission risk for diabetic patients with CVD (Rubin et al., 2017).
To be included in Rubin et al.’s (2017) study, the patient’s primary discharge
diagnosis had to be CVD, which included heart attack, heart disease, stroke, peripheral
vascular disease, and diabetes. The researchers believed that if the readmission risk of
this population could be predicted, the patients identified as high risk could be singled out
which would enable resources to be used more efficiently and effectively. The results of
the study revealed vast similarities in the predictors of the DERRITM and the DERRICVDTM.
The most common shared 30-day readmission predictors in Rubin et al.’s (2017)
study were diabetes, heart failure, shortness of breath, chest pain, peripheral arterial
disease, and acute kidney failure. The results of the DERRI-CVDTM were similar to the
DERRITM; therefore, either model may be useful for identifying diabetic patients
admitted with CVD who are at an elevated risk for a 30-day readmission. All these
predictors are easily gathered at the time of patient admission, health administrators may
utilize the tool to implement protocols focused on diabetic CVD patients with high risks
for 30-day readmissions. This tool may help to lower the financial burdens to healthcare
facilities while improving patient outcomes (Rubin et al., 2017).
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Socioeconomic Status and Hospital Readmission Rates
Socioeconomic status is a significant determinant of health among patients with
diabetes (Assari, Moghani Lankarani, Piette, & Aikens, 2017). Researchers around the
world have reported that social characteristics, such as low education, low income,
marital status, and race, are associated with increased risks for diabetes. Likewise,
comparative trends have been documented for readmission frequency and rate among
diabetic patients (Assari et al., 2017).
Assari et al. (2017) conducted a cross-sectional study using a consective sampling
strategy. The purpose of the study was to evaluate the differences between
socioeconomic status (SES) and Hemoglobin A1c (HbA1c) levels among Black and
White patients with T2DM. The researchers found that SES had a greater impact on the
HbA1c levels of Black males than any other subgroup in the study. Findings also
revealed that Black males and females developed diabetes at a younger age than White
males and females. The results of the study may contribute to governmental policy
reform, but more research is needed among a larger sample (Assari et al., 2017).
Diabetic ketoacidosis (DKA) is one of many acute complications of Type 1
diabetes mellitus (T1DM) and a leading cause of death in children and young adults with
the disease (Everett & Mathioudakis, 2019). Everett and Mathioudakis (2019) conducted
a cross-sectional study using the National Readmission Database (NRD) to identify
181,284 T1DM patients admitted for DKA between 2010 and 2015. The purpose of the
study was to examine patient- and hospital-level predictors of T1DM patients with
recurrent DKA who were admitted or readmitted with a special focus on patient
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socioeconomic status. To be included in the study, the admission had to be the first
admission for the patient within the specific calendar year and the primary diagnosis had
to be recurrent DKA. Results revealed that participants from the lowest socioeconomic
income quartile had a 50% chance of four or more hospital readmissions with DKA
within a single calendar year. The researchers also reported that patients with government
insurance (i.e., Medicare or Medicaid) were at an increased risk of hospital readmissions
with DKA, as well as those who went home against the advice of medical professionals.
The researchers concluded that further investigation was needed to examine the
relationship between DKA and hospital readmissions among this high-risk subgroup.
Such research may reveal which types of interventions such as patient education or
community outreach will help this population (Everett & Mathioudakis, 2019) .
Across the globe, it is estimated that one person dies from diabetes-related
complications, every six seconds (Bird, Lemstra, Rogers, & Moraros, 2015). In 2011, the
Public Health Agency of Canada (PHAC) published a report on diabetes that determined
the primary adjustable risk factors for diabetes were obesity, lack of physical activity,
smoking, and unhealthy eating habits. The non-adjustable risks factors included race and
recent immigration status, but the report did not mention correlations with socioecomonic
status or income.
A cross-sectional population-based study conducted by Bird et al., (2015) was
conducted to determine if a correlation existed between T2DM and socioecomonic/
income status in the Canadian province of Saskatchewan. Data collected from the
Canadian Community Health Survery (CCHS) between 2000 and 2008 were analyzed.
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The CCHS is a self reporting survey. The sample included 27,090 residents. Four distinct
and separate models were built, which examined the effect of income on T2DM in
correlation wih the conditions of hypertension, obesity, and physical activity. Study
results revealed that socioeconmic status was closely associated with T2DM and its
underlying comorbidites, such as hypertension and obesity. Internationally, findings from
this study provide evidence that socioeconomic and income status may relate to increased
morbidity and mortality (Bird et al., 2015).
Care Discrepancies by Insurance Status
Readmission among diabetic patients may also relate to insurance status. Basu et
al. (2018) indicated insurance status is associated with aspects of post-acute care, which
correlates with readmission rates. Those without insurance may lack access to follow-up
care, and care decisions for patients with public insurance are often driven by financial
incentives (Cai et al., 2015). Other researchers have reported similar trends regarding the
influence of insurance status on care outcomes. Englum et al. (2016) examined the
relationship between hospital status and length of stay among trauma patients and found
that uninsured patients had significantly shorter lengths of stay than patients with private
insurance. Publicly insured patients in Englum et al.’s study had the longest lengths of
stay; however, this does not necessarily indicate that publicly insured patients received
the best care. In fact, many researchers have reported that longer lengths of stay are
associated with higher risks for 30-day readmission (Chakraborty et al., 2017).
Discrepancies in resource use among underinsured patients may reflect the shorter
lengths of stay (Englum et al., 2016), but do not explain the lower rates of readmission
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among this group. Basu et al. (2018), who also found readmission rates to be lower
among the underinsured, posited that the phenomenon was the result of the lack of
insurance coverage and poor access to care – particularly among minorities. Accordingly,
the researchers cautioned that lower readmission rates may not generally be interpreted as
a decent result (Basu et al., 2018).
A substantial body of literature indicates that uninsured patients receive
inefficient and lower quality care than insured patients; however, less is known about
differences in the quality of care provided to privately-insured versus publicly-insured
patients (Englum et al., 2016). Some researchers have reported publicly insured patients
undergo fewer procedures (Haas & Goldman, 1994; Wenneker, 1990) and have worse
morbidity (Ayanian et al., 1993; Braveman et al., 1994) than the privately-insured. Other
researchers have reported incongruence in findings comparing mortality rates among
publicly and privately insured patients (Englum et al., 2016).
To date, interventions aimed at reducing 30-day readmissions among diabetes
patients have demonstrated inconsistent outcomes (Hansen et al., 2011; Rubin et al.,
2017). Such interventions have focused on improving discharge planning and
transactional care and providing patients with timely follow-up (Drincic et al., 2017). As
Rubin et al. (2017) explained, applying general interventions, especially when they only
demonstrate modest effects, across patient populations is cost-prohibitive. Thus, it is
important to identify patients at the greatest risk of 30-day readmission in order to more
efficiently utilize resources. Similarly, Dugan and Shubrook, (2017) suggested that
targeting interventions to high-risk groups could improve cost-to-benefit ratios.
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Structured and individualized discharge plans may help reduce 30-day readmission
among patients at the highest risk (ADA, 2019). As Basu et al. (2018) urged, the role of
insurance should be examined in order to evaluate efforts to reduce readmissions. In
addition, because readmission rates may be the result of differences in patient
characteristics (Basu et al., 2018; Carey & Lin, 2015; Singh et al., 2014), it is also
important to understand how patients’ demographic characteristics may moderate the
relationships between insurance payer status and readmission rates.
Definitions
Following are definitions of key terms that will be used throughout this study:
30-day readmission: Rehospitalization that occurs within 30 days of discharge
from the initial hospitalization (Rubin et al., 2017).
Centers for Medicaid and Medicare (CMS): A unit within of the Department of
Health and Human Services (CMS, 2017).
Diabetes mellitus (DM): A chronic disease caused by an inherited or acquired
deficiency in production of insulin by the pancreas. Symptoms of the disease include
excessive urination, elevated blood sugar, and insulin resistance (CMS, 2017).
Diabetic ketoacidosis (DKA): A serious acute complication of Type 1 diabetes
caused by a build-up of acid in the blood (Everett & Mathioudakis, 2019).
Diagnosis-related group (DRG): A statistical method of classifying inpatient
stays into groups, which assists with insurance compensation (CMS, 2017).
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Excess readmission ratios (ERRs): A measure of a hospital’s readmission
performance compared to the national average for hospitalized patients with applicable
conditions (CMS, 2017).
Healthcare Cost and Utilization Project (HCUP): A family of health care
databases and related software tools and products developed through a federal and state
industry partnership and sponsored by the Agency for Healthcare Research and Quality
(CMS, 2017). The HCUP databases bring together the data collection efforts of state data
organizations, hospital associations, private data organizations, and the federal
government to create a national information resource of encounter-level health care data
(CMS, 2017).
Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS):
The first national, standardized, and publicly reported survey of patients’ views of the
care they receive in hospitals (CMS, 2017). The survey is also known as the CAHPS
hospital survey. The survey consists of 27 question about patients’ hospital stays, 18 of
which are related to critical elements of the patient hospital experience (CMS, 2017).
Hospital Readmissions Reduction Program (HRRP): A pay-for-performance
program that lowers payments to Inpatient Prospective Payment System (IPPS) hospitals
that have too many readmissions (Centers for Medicare and Medicaid Services, 2017).
Medicaid: A state and federally funded program that provides health coverage to
eligible low-income adults, children, pregnant women, older adults, and people with
disabilities (CDC, 2017). The program is state-administered in compliance with federal
requirements (CDC, 2017).
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Medicare: A single-payer, national social insurance provider governed by the
United States government (CMS, 2017).
National Inpatient Sample (NIS): One of the HCUP databases that is the most
extensive and publicly available all-payer inpatient health care database in the United
States, yielding national estimates of hospital inpatient stays (CMS, 2017).
Primary payer status: An indicator of insurance type, categorized by the party
responsible for payment (Xu et al., 2017). In this study, primary payer status was
categorized into the following four groups: Medicare, Medicaid, uninsured, and private
insurance.
Private insurance: Any type of health insurance that is purchased by an individual
or obtained through an employer (Delaware Assistive Technology Initiative, n.d.). Unlike
Medicare and Medicaid, private insurance is not federally funded.
Race: Groups of people who have differences and similarities in biological traits
deemed by society to be socially significant (CMS, 2017).
Readmission: The return of a patient to a healthcare facility after being previously
discharged for the same illness (CMS, 2017).
Type 2 diabetes mellitus (T2DM): A form of diabetes in which the pancreas
produces too little insulin, or the body rejects the insulin that it produces. T2DM can
usually be controlled with medication, diet, and exercise (Georgia Department of Public
Health, 2018). T2DM is the form of diabetes that was focused on in this study.
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Assumptions
The first assumption of this study was that the HCUP NRD database would
contain all the necessary variables for the study for T2DM. Variations may be shown
depending on the geographical location in which data is derived to demonstrate
differences in readmission rates and insurance status. It was also assumed that all utilized
data have been accurately entered into the HCUP NRD database.
Scope and Delimitations
The scope of the study was based on the Healthcare Cost and Utilization Project
(HCUP) Nationwide Readmission Database (NRD), 2015. This investigation only
included readmission data for patients who were admitted to hospitals nationally between
Jan 1, 2015 and Dec 31, 2015. Nationally was selected as the focus of this investigation
because 9.4% of the population has diabetes (American Health Rankings, 2019).
This study was also limited by the payer status categories selected. For example, a
status of private insurance included any type of insurance plan purchased by an
individual or provided by an employer. Differences across types of private insurance
were not included. The researcher also selected to examine Medicare and Medicaid
separately rather than combining them under the category of public insurance, as many
previous researchers have. Findings may differ if the definition and organization of payer
status was different.
Other delimiting factors included the researcher’s selection of conceptual
framework and study method and design. The demographic factors selected for
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examination as moderators also represented a delimitation. The use of other demographic
factors, such as household income, may have resulted in different findings.
Significance, Summary, and Conclusions
Findings from the study may have an impact for positive social change by
informing health care providers and administrators regarding a correlation, if any,
between health insurance payers and readmission rates. Healthcare providers and leaders
can create programs to ensure all patients with a primary or secondary diagnosis of
diabetes, receive appropriate care and education to reduce readmissions, improve health
outcomes, and improve quality of life for this patient population, and result in significant
financial savings.
The study may also inform government policymakers with analytical data needed
to amend the guidelines for the Hospital Readmissions Reduction Program (HRRP)
(Krinsky et al., 2017). The study may inform hospital administrators regarding
readmissions and diabetics to align their organization with healthcare reform guidelines
associated Medicare spending and the HRRP. The impact of this alignment may improve
care transitions between patients and healthcare organizations. The study results may also
lead to improved outcomes for patients to further social good, by relieving the patient of
the burden of returning to the hospital, which can also result in a burden relief to the
taxpayers because of the high costs of readmissions.
Summary
A review of the literature on hospital readmission among patients with diabetes
has revealed the lack of distinction between planned and unplanned readmissions
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(Drincic et al., 2017) and mixed findings regarding the influence of insurance payer
status on readmissions among patients with T2DM. The researcher of this study sought to
provide evidence to fill a gap in the literature regarding the correlation, if any, between
readmission rates and insurance payer status among patients with T2DM. A review of
existing research on readmission rates revealed that patients with diabetes have higher
readmission rates than those without diabetes; yet limited information exists on efforts to
reduce readmissions among these patients (Drincic et al., 2017). Lawmakers have
suggested that healthcare organizations implement strategies to reduce readmissions to
lower cost (Drincic et al., 2017). The strategies focus on identifying risk factors that may
be associated with readmissions such as underlying comorbidities, age, the severity of
illness, previous hospitalization and low socioeconomic status (Drincic et al., 2017).
Applying general interventions across patient populations is cost-prohibitive. It is
important to identify patients at the greatest risk of 30-day readmission in order to more
efficiently utilize resources.
An examination of the relationship between insurance payer status and 30-day
readmission rates among T2DM patients may provide leaders with information needed to
target appropriate interventions and reduce readmission rates. In addition, because
readmission rates may be the result of differences in patient characteristics (Basu et al.,
2018; Carey & Lin, 2015; Singh et al., 2014), it is also important to understand how
patients’ demographic characteristics may moderate the relationships between insurance
payer status and readmission rates. The study addressed these important gaps in the
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existing literature with the aim of developing findings that may be used to reduce
readmission among patients with T2DM
In Section 1, I presented an introduction to the investigation and an overview of
the literature associated with readmission rates among patients with T2DM. The next
section presents methodological details of the study. Discussions about the study design,
population, sample, data analysis plan, data cleaning, and RQs are provided in Section 2.
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Section 2: Research Design and Data Collection
Introduction
The purpose of this quantitative, correlational study was to use secondary data to
examine the relationship between primary payer status (Medicare, Medicaid, uninsured,
or private insurance) and hospital readmission rates among individuals whose primary or
secondary reason for admission was T2DM. In addition, I analyzed whether
sociodemographic factors (age, gender, and income) moderate the relationship between
primary payer status (Medicare, Medicaid, uninsured, or private insurance) and hospital
readmission rates among individuals whose primary or secondary reason for admission
was T2DM. In Section 2, I will detail the research design and rationale and methodology.
In the section, I will discuss the target population, sampling design, instrumentation, and
data analysis plan. I also discuss issues of validity and the ethical procedures used in
working with study data.
Research Design and Rationale
The research method applied to assess the hypotheses was a quantitative
multivariate analysis and the Donabedian framework. Logistic regression analysis testing
helped to determine if there was a direct relationship between the readmission rate and
insurance payer status for patients with T2DM as a primary or secondary diagnosis and
30- day readmission rates. It was also helpful in determining whether a relationship
existed when controlling for age, gender, and income. I performed a quantitative analysis
to verify the data in the Statistical Package for the Social Sciences (SPSS). I reviewed
multiple studies that had similar and consistent data when controlling for covariates
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similar to the ones used in the study. The research design allowed me to measure data
from the target population and quantified the prevalence of multiple characteristics within
the sample population. I used the quantitative research method to determine patterns in
payer status and 30-day readmission rates for patients nationally with T2DM.
Methodology
I analyzed the 2015 NRD of the HCUP using logistic regression to establish a
relationship between the variables. To verify the data, I conducted a quantitative analysis
using SPSS. To obtain secondary data from HCUP NRD, I completed a mandatory data
use agreement course that included discussion of the key elements of using secondary
data from the HCUP website. A certificate code was then issued to access the secondary
data set electronically; the code provided authorization to use the data for research
concentrated in the United States.
Population
The focus of this research was on individuals who are medically diagnosed with
T2DM nationally. The inclusion of all patients with T2DM nationally was a requirement
to assess the hypothesis and determine if there was a correlation between 30-day
readmission rates and insurance payer status and between 30-day readmission rates and
sociodemographic variables for patients with T2DM. I excluded patients who were not
medically diagnosed with T2DM from the research study. I did not exclude participants
based on their gender, ethnicity/ race, age, physical disability, or preexisting
comorbidities; rather, I used the covariates to further determine additional factors that
may show disparities.
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Sampling Design
I used a quantitative correlational design to examine the relationship between
insurance primary payer status (Medicare, Medicaid, uninsured, or private insurance) and
hospital readmission rates among individuals whose primary or secondary reason for
admission was T2DM. I also examined sociodemographic variables, insurance payer
status, and 30-day readmission rate for patients with T2DM. A correlational research
design allows for the measurement of a relationship between two variables without the
researcher controlling either of them (Creswell, 2009). A correlational design was the
most appropriate method to examine the relationship between insurance payer status and
30-day readmission rates for patients with T2DM.
I used a secondary data set in the research study acquired from the HCUP NRD
for the time period of 2013 to 2015. HCUP-NRD is the Nationwide Readmission
Database and software tools developed for the HCUP (HCUP, 2015). The NRD includes
inpatient discharge records form community hospitals in the United States. I used the
HCUP-NRD to look at the 30-day readmission rate for patients nationally whose primary
or secondary reason for admission was T2DM. I used insurance payer type while
simultaneously controlling for covariates categorized from the secondary data set.
Data analysis. I analyzed the secondary data by using IBM SPSS Statistics v.
23.0 (2016). The statistical analysis consisted of conducting a descriptive analysis, a twoway test of association, followed by multivariate logistic regression to address RQ1 and
logistic regression to address RQ2. Categorical variables were investigated to determine
the percentage of male and female subjects and to define by race/ethnicity in each
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category. Additional analysis assisted with categorizing the number of subjects by
medical condition and year. The mean, mode, and standard deviation were calculated per
category to exhibit variations per year. The research analyses assisted in establishing a
pattern of 30-day readmission rates for patients nationally with T2DM and determining
insurance payer status and 30-day readmission rates for patients with T2DM nationally.
The covariates were analyzed to determine if there was a pattern associated with 30-day
readmission rates, sociodemographic variables, and insurance payer status for T2DM
patients nationally.
Power analysis. I completed a power analysis using IBM SPSS Statistics v. 23.0
(2016) with .80 power and alpha of < .05 to determine the sample size needed for each
RQ. The power analysis calculation sample size revealed a minimum sample size of 398
for RQ1 with power .80 and alpha < .05. This sample size needed to be significant to
determine if there was a correlation between insurance primary payer status (Medicare,
Medicaid, uninsured, or private insurance) and 30-day readmission rates among
individuals whose primary or secondary reason for admission was T2DM nationally.
The power analysis for RQ2 for .80 power and an alpha < .0 also revealed a
minimum required sample size of 398. This sample size needed to be significant to
determine whether sociodemographic factors such as age, gender, and income moderate
the relationship between insurance primary payer status (Medicare, Medicaid, uninsured,
or private insurance) and 30-day readmission rates among individuals whose primary or
secondary reason for admission was T2DM nationally.
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Data Analysis Plan
I used the HCUP NRD for 2013 to 2015 for the study. To analyze the data, I
performed logistic regression using SPSS. Logistic regression is the multivariate
extension of a bivariate chi-square analysis (Sperandei, 2014). Logistic regression allows
the researcher to control for various demographic, analytical, clinical, and potentially
confounding factors that affect the relationship between a primary predictor variable and
a dichotomous categorical outcome variable (Sperandei, 2014). Logistic regression
generates adjusted odds ratios with 95% confidence intervals (Sperandei, 2014). Once the
calculations have been received, the logistic regression analysis will assist in determining
a null or alternative hypothesis.
The dependent variable was the 30-day hospital readmission rate and was
analyzed in conjunction will the independent variables of insurance payer status
(Medicare, Medicaid, uninsured or private insurance). The covariates within the research
were comprised of age, gender, income, and timeframe in which services rendered
ethnicity/race, and comorbidities. The location of the research was nationally, and the
ethnicity consisted of Non-Hispanic/White, Asian/Pacific Islander, Black/AfricanAmerican, Hispanic, and Native American/Alaska Native. The timeframe for the research
included three consecutive years of data to exhibit a current study aimed at exploring the
gap in literature and current and past findings pertaining to the dependent and
independent variables. The secondary data set was analyzed to address the following
research study questions and corresponding hypotheses:
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RQ1. What is the relationship, if any, between primary payer status Medicare,
Medicaid, uninsured, or private insurance and 30-day readmission rates among
individuals whose primary or secondary reason for admission was T2DM nationally?
H01. No statistically significant relationship exists between primary payer status
Medicare, Medicaid, uninsured, or private insurance and 30-day readmission rates among
individuals whose primary or secondary reason for admission was T2DM nationally.
HA1. A statistically significant relationship exists between primary payer status
Medicare, Medicaid, uninsured, or private insurance and 30-day readmission rates among
individuals whose primary or secondary reason for admission was T2DM nationally.
RQ2. Do sociodemographic factors like age, gender, income moderate the
relationship between primary payer status like Medicare, Medicaid, uninsured, or private
insurance and 30-day readmission rates among individuals whose primary or secondary
reason for admission was T2DM nationally?
H02. Sociodemographic factors like age, gender, income do not moderate the
relationship between primary payer status like Medicare, Medicaid, uninsured, or private
insurance and hospital 30-day rates among individuals whose primary or secondary
reason for admission was T2DM nationally.
HA2. Sociodemographic factors like age, gender, income moderate the
relationship between primary payer status like Medicare, Medicaid, uninsured, or private
insurance and 30-day readmission rates among individuals whose primary or secondary
reason for admission was T2DM nationally.
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Threats to Validity
In this quantitative study, the research identified, if there was the possibility of
external and internal threats to validity. Internal and external validity are perceptions that
replicate if the results of a study are trustworthy and meaningful (Anrade, 2018). Internal
validity relates to how well a study is conducted external validity relates to how
applicable the findings are to the real world (Anrade, 2018).
Internal Validity
Internal validity examines whether the manner in which a study was designed,
conducted, and analyzed allows trustworthy answers to the RQs in the study (Anrade,
2018). There could be numerous threats to internal validity such as, improper
randomization, inadvertent unblinding of patients or raters, missing data. Internal validity
is based on judgment and is not a computed statistic (Anrade, 2018). Internal validity
examines the extent to which bias is present.
External Validity
External validity of the study may be affected if the study population is not a true
representation of the target population that is eligible for the study (Anrade, 2018).
External validity pertains to appropriate inferences or generalizations of research results
to other populations (Rooney et al., 2016). Random sampling was chosen to assure the
validity of the study.
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Data Protection and Privacy
Treatment of Data
The research study underwent the approval process from Walden University
Institutional Review Board (IRB) to utilize an external secondary dataset. The Data
Protection Act 2018 (DPA) (updated to the 1998 DPA) protects individuals from being
exploited and their personal information from unwanted distribution (Spencer & Patel,
2019). This update to the DPA was necessary due to the ongoing technological advances
of social media. The data protection act ensures that Protected Health Information (PHI)
is safeguarded. PHI includes an individual’s demographic information, such as age, date
of birth, Social Security number, address, and telephone number (Craig, 2017). The
Health Insurance Portability and Accountability Act (HIPAA) privacy rule requires
healthcare providers to maintain the confidentiality of a patient’s protected health (Craig,
2017).
Permissions
For this doctoral research, before data collection could begin, the IRB had to
review and approve the methods and procedures that the researcher planned to use. To
obtain secondary data from HCUP, a mandatory data use agreement course was
completed that discussed the key elements of utilizing secondary from the HCUP website
(Agency for Healthcare Research and Quality, 2019). A certificate code was then issued
to access the secondary dataset electronically and provide authorization for utilizing data
to conduct testing for the research.
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Ethical Concerns
The protection of human subjects during research requires permission for
academic institutions and clinical trials. All patient specific information was protected
and underwent re-coding where necessary to uphold patient privacy during the duration
of the research study. Approval from Walden IRB and HCUP privacy agreement use
were obtained. The research does not present any ethical issues for the university,
researcher, or the participants to further determine gaps in previous related literature.
Ethical Procedures
In meeting the requirements of Walden’s standards, this was a Walden doctoral
study which required the approval of the Institutional Review Board (IRB) to fulfill all
the requirements of Walden University. As a researcher, the ethics of confidentiality and
data security are important. To alleviate research bias, only data gathered from a public
database was used for this study.
Permission
The 2015 HCUP NRD is a public database; therefore, there was not direct contact
with participants in this study. Permission to obtain and use this data was obtained after
completion of the HCUP Data Use Agreement Training Course. Before data collection
can begin on a project, the IRB must review and approve the methods and procedures that
will be used. Prior to implementation of this practice change, appropriate knowledge and
training regarding human research subject matter protections, ethical conduct of research,
applicable regulations.
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Summary
This section presented the methodology of the quantitative study. The description
about population, sampling, design, and rationale for data collection and analysis were
described. Section 3 will provide the interpretation of the results of the data, results, and
findings, and summarize answers to the RQs.
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Section 3: Presentation of the Results and Findings
Introduction
In Section 3, I will review the data collection and statistical analysis of the
secondary data discussed in Section 2. The objective of the research study was to
determine whether there was a correlation between 30-day readmission rates among
patients whose primary or secondary reason for admission was T2DM, while controlling
for multiple covariates. I calculated and analyzed a number of descriptive and inferential
statistics, including the frequency, standard deviation, average, percentage, mean, mode,
sum, and differences of the participants.
I retrieved participants from the HCUP nationwide readmissions database of the
2015 NRD, which is an extensive, publicly available inpatient database containing data
on over 7,000,000 hospital stays in the United States (HCUP, 2015). Logistic regression
was the primary analysis employed for this research. The RQs and hypotheses for this
study were,
RQ1. What is the relationship, if any, between primary payer status (Medicare,
Medicaid, uninsured, or private insurance) and 30-day readmission rates among
individuals whose primary or secondary reason for admission was T2DM nationally?
H01. No statistically significant relationship exists between primary payer status
(Medicare, Medicaid, uninsured, or private insurance) and 30-day readmission rates
among individuals whose primary or secondary reason for admission was T2DM
nationally.
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HA2. A statistically significant relationship exists between primary payer status
(Medicare, Medicaid, uninsured, or private insurance) and 30-day readmission rates
among individuals whose primary or secondary reason for admission was T2DM
nationally.
RQ2. Do sociodemographic factors like age, gender, and income moderate the
relationship between primary payer status (Medicare, Medicaid, uninsured, or private
insurance) and 30-day readmission rates among individuals whose primary or secondary
reason for admission was T2DM nationally?
H02. Sociodemographic factors like age, gender, and income do not moderate the
relationship between primary payer status (Medicare, Medicaid, uninsured, or private
insurance) and hospital 30-day rates among individuals whose primary or secondary
reason for admission was T2DM nationally.
HA2. Sociodemographic factors like age, gender, and income moderate the
relationship between primary payer status (Medicare, Medicaid, uninsured, or private
insurance) and 30-day readmission rates among individuals whose primary or secondary
reason for admission was T2DM nationally.
Data Collection of Secondary Data Sets
I filtered the available raw data of the NRD database to review the study variables
for the doctoral study. The initial sample size for the secondary data set comprised over
500,000 cases for 2013, 2014, and 2015. All three years were reviewed. I focused on the
most current year of the 2015 NRD dataset, which resulted in a sample size of 41,068.
The data set was filtered to include age, gender, income, diagnosis, and insurance payer

53
status. Participants in the data set included 41,068 patients with T2DM. The age range of
the participants was 20 to 90 years old.
Results
A binary logistic regression was the analysis to test the contributions of primary
payer status (i.e., Medicare, Medicaid, uninsured, or private insurance) in predicting the
likelihood that respondents, with diabetes without complications, would be readmitted
within 30 days. With the dependent variable being dichotomous, logistic regression was
the appropriate statistical analysis because it permitted the examination of the odds of
membership in one of the two outcome groups (i.e., under 30 days, more than 31 days).
The χ2 omnibus test of model coefficients was used to assess whether adding the
independent variables significantly increased the ability to predict hours per week
worked. Additionally, I used the Nagelkerke R2 to assess the percentage of variance
accounted for by the independent variables. Finally, the predicted probabilities of an
event occurring were determined by examining the odds ratio. Preliminary analyses of
the data set were conducted to observe whether the assumptions of logistic regression
were met.
Participants
Participants in the data set included 41,856 diabetes patients. The largest income
bracket was those in the $1-$41,999 range (34.1%). A majority (53.7%) were female, and
the largest age group was those who were 60 years of age and older (N = 30,309). Most
participants used Medicare (68.4%). For the additional analysis, the majority of the
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sample identified had diabetes with complications (61.7%). The frequencies are presented
in Table 2.

Table 2
Demographic Frequencies
Variables
Income

Payment status

Gender
Age brackets

Categories
$1-41,999
42,000-51,999
52,000-67,999
68,000 and higher

N
14,288
10,382
9,499
7,072

%
34.1
24.8
22.7
16.9

Medicare
Medicaid
Private Insurance
No Insurance

27,906
5,419
6,593
843

68.4
13.3
16.2
2.07

Male
Female

19,397
22,517

46.3
53.7

20-29
30-39
40-49
50-59
60 and older

741
1,513
2,986
6,365
30,309

1.77
3.61
7.12
15.19
72.31

RQ1 and its corresponding hypotheses were as follows:
RQ1. What is the relationship, if any, between primary payer status (Medicare,
Medicaid, uninsured, or private insurance) and 30-day readmission rates among
individuals whose primary or secondary reason for admission was T2DM nationally?
H01. No statistically significant relationship exists between primary payer status
(Medicare, Medicaid, uninsured, or private insurance) and 30-day readmission rates
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among individuals whose primary or secondary reason for admission was T2DM
nationally.
HA1. A statistically significant relationship exists between primary payer status
(Medicare, Medicaid, uninsured, or private insurance) and 30-day readmission rates
among individuals whose primary or secondary reason for admission was T2DM
nationally.
First, I examined the assumptions. The multicollinearity tolerance values for the
independent values ranged from 1.73 to 8.90, which lies between the 1-10 range;
therefore, multicollinearity was not present (see Hair, Anderson, Tatham, & Black,
1995). Next, an inspection of the data (see Table 1) confirmed that the ratio of cases to
variables was adequate. Finally, the Hosmer and Lemeshow Goodness-of-Fit test was
conducted to test the null hypothesis that the data fit the specified model, χ2(3) = 0.001, p
= 1.00, and the test was not statistically significant; therefore, a non-statistical result
indicated that the data indeed fit the specified model. As a result, the null hypothesis was
retained.
Medicare and those without insurance were significant predictors of being
readmitted within 30 days. Those with Medicaid (95% CI: 0.76 – 0.92; p = .001) had a
45.76% probability of being re-admitted within 30 days while those with no insurance
(95% CI: 0.76 – 0.94; p = .002) also had a 45.76% probability of being re-admitted
within 30 days. The overall model was statistically significant χ2(4) = 40.95, p = 0.001.
Additionally, the four independent variables explained only 1% (Nagelkerke R2) of the
variance for the probability of being re-admitted and correctly classified 71.8% of the
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cases. As a result, for H01, the null hypothesis was rejected, and the alternative
hypothesis was accepted. The results are presented in Table 3.

Table 3
Logistic Regression Analysis of Hospital Readmission with OR, 95% CI, Wald and P Values
(N = 41,856)
OR
Variables
Medicare
Medicaid
Private Insurance
No Insurance
Constant

1.25
1.16
1.05
1.22
2.22

95% CI
Lower
Upper
1.10
1.43
1.01
1.33
0.92
1.21
1.00
1.48

Wald

P

11.63
4.22
0.51
3.77
135.90

0.001
0.040
0.474
0.052
0.001

Research Question 1
For the first RQ, a binary logistic regression was the statistical analysis to
examine which independent variables were significant in predicting 30-day readmission.
Readmission analyses often consider the time between the end of one admission and the
start on the next admission, where the number of days between the beginning of each
entry was coded ‘0’ for readmission within 30 days or less and ‘1’ for re-entry over 31
days. To calculate this date, the verified patient linkage (i.e., NRD-visitLink) variable
was used.
The NRD-visitLink variable is a data element created for the Nationwide
Readmissions Database to track patients across hospitals in a year. For this dataset, if a
patient had more than two rows of data, then they were readmitted. Data were transposed
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on the patient linkage variable, and the number of days between each admission was
calculated. The frequency of those being admitted within 30 days was 28.1% (N =
11,884) compared to those who were not (N = 30,344). For RQ2, a hierarchal logistic
regression was the statistical procedure to examine which demographic variables were
significant in moderating the 30-day readmission rate.
Research Question 2
RQ2. Do sociodemographic factors like age, gender, and income moderate the
relationship between primary payer status (Medicare, Medicaid, uninsured, or private
insurance) and 30-day readmission rates among individuals whose primary or secondary
reason for admission was T2DM nationally?
H02. Sociodemographic factors like age, gender, and income do not moderate the
relationship between primary payer status (Medicare, Medicaid, uninsured, or private
insurance) and hospital 30-day rates among individuals whose primary or secondary
reason for admission was T2DM nationally.
H12. Sociodemographic factors like age, gender, and income moderate the
relationship between primary payer status (Medicare, Medicaid, uninsured, or private
insurance) and 30-day readmission rates among individuals whose primary or secondary
reason for admission was T2DM nationally.
A hierarchal binary logistic regression was the statistical analysis to test the
contributions of primary payer status (i.e., Medicare, Medicaid, uninsured, private
insurance) along with the moderating variables of age, gender, income in predicting the
likelihood that respondents, with diabetes without complications, would be readmitted
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within 30 days. Age was treated as a continuous variable, while gender and income were
dummy coded. First, the assumptions were examined. The multicollinearity tolerance
values for the independent values ranged from 1.01 to 9.35, which lies between the 1-10
range; therefore, multicollinearity is not present (Hair et al., 1995).
Next, an inspection of the data (See Table 1), confirmed that the ratio of cases to
variables was adequate. The Hosmer and Lemeshow Goodness-of-Fit test was conducted
to test the null hypothesis that the data fit the specified models for model 1, χ2(8) =
12.681, p = .123, and for model 2 χ2(8) = 6.573, p = .583. Both tests for models 1 and 2
were not statistically significant; therefore, a non-statistical result indicated that the data
does indeed fit the specified model. As a result, the null hypothesis was retained.
The first model (i.e., step one), which only considered the socioeconomic
variables, was significant χ2(5) = 33.18, p = .001. Both gender and age were significant
predictors of being readmitted within 30 days. Females had a .91 (95% CI: 0.87 – 0.95)
times higher odds of being readmitted within 30 days, compared to males. Additionally,
as age increased by one unit, the odds increased by 1.00 (95% CI: 1.00 – 1.00). Overall,
model one correctly classified 71.9% of the cases. The second model, which took the
socioeconomic variables and the payment methods, was also significant χ2(9) = 64.26 p =
.001.
In this model, gender was the only socioeconomic variable to moderate readmission
status. Females had a .91 (95% CI: 0.87 – 0.95) times higher odds of being
readmitted within 30 days, compared to males. Additionally, Medicare was a
significant predictor of being readmitted where those with Medicare were .80 (95%
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CI: 0.87 – 0.95) times higher odds of being readmitted. Model two correctly
classified 71.9% of the cases and explained less than 2% of the variance. As a
result, for H02, the null hypothesis was rejected, and the alternative hypothesis was
accepted. The results are presented in Table 4.
Table 4
Hierarchical Logistic Regression Analysis of Hospital Readmission with OR, 95%
CI, Wald, and P Values (N = 41,856)
OR

95% CI
Lower Upper

Variable

Wald

P

Model 1
Female
Ages 20-29
Ages 30-39
Ages 40-49
Ages 50-59
Income 1 - 41,999
Income 42,000 - 51,999
Income 52,000 - 67,999
Constant*

1.11
0.91
0.74
0.99
1.00
1.04
1.04
0.97
2.41

1.07
0.77
0.67
0.91
0.94
0.98
0.97
0.90

1.16
1.07
0.83
1.08
1.06
1.11
1.11
1.03

23.72
1.32
27.36
0.06
0.03
1.71
1.26
0.99
907.71

0.001
0.250
0.001
0.813
0.868
0.191
0.261
0.320
0.001

1.06
0.84
0.72
0.98
1.01
0.97
0.97
0.90
1.09
0.98
0.91
0.98

1.16
1.18
0.91
1.17
1.15
1.10
1.11
1.04
1.43
1.30
1.20
1.46

20.72
0.00
12.45
2.00
4.37
1.14
0.98
0.93
10.57
2.59
0.40
3.02
91.50

0.001
0.967
0.001
0.157
0.037
0.287
0.323
0.336
0.001
0.107
0.528
0.083
0.001

Model 2
Female
Ages 20-29
Ages 30-39
Ages 40-49
Ages 50-59
Income 1 - 41,999
Income 42,000 - 51,999
Income 52,000 - 67,999
Medicare
Medicaid
Private Insurance
No Insurance
Constant*

1.11
1.00
0.81
1.07
1.08
1.04
1.04
0.97
1.25
1.13
1.05
1.19
1.99
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The reference group contains male participants in the 60 and over age range and those
with an income of $68,000 more.

Additional Analysis
For both RQs, I only analyzed patients who had diabetes without complications;
however, I was interested in whether there was a significant difference between those
with (N = 62,627) and without complications (N = 41,184) regarding readmitted status.
Those who had diabetes with without complications were coded as ‘0’ and those with
diabetes with complications were coded as ‘1.’ The logistic regression results revealed a
significant relationship χ2(1) = 200.07, p = 0.001 and correctly identified 74.2% of the
cases. Those with complications (95% CI: 1.19 – 1.26; p = .001) had a 75.7% predicted
probability of being re-admitted within 30 days while those who did not have
complications had only a 71.83% probability of being admitted within 30 days. This
model explained approximately 1% of the variance. The results are presented in Table 5.

Table 5
Logistic Regression Analysis of Hospital Readmission with OR, 95% CI, Wald,
and P values (N = 103,811)
OR
Variable
With Complications
Constant

1.22
2.55

95% CI
Lower
Upper
1.19
1.26

Wald

p

201.14
7431.22

0.001
0.001
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Summary
In this section I used a descriptive analysis to summarize the variables and
measurements within the research study, utilizing a quantitative analysis. The Hosmer
and Lemeshow Goodness-of-Fit test was conducted to test the null hypothesis to ensure
that the data fit the specified models for both RQs. The objective of the binary logistic
regression was to establish which variables correlated to the 30-day readmission rate for
patients with diabetes and determine the odds ratio, 95% confidence interval, and the
statistical significance of each variable.
Participants in the data set included 41,068 diabetes patients. The largest income
bracket was those in the $1 - $41,999 range (34.1%). A majority (53.8%) were female,
and the age range of all participants was grouped between 20-29, 30-39, 40-49, 50-59,
and 60- 90 years old (M = 67.26, SD = 15.68). Most participants used Medicare (67.9%).
For the additional analysis, the majority of the sample identified had diabetes with
complications (62.1%).
The null hypothesis for RQ1 was retained. No statistically significant relationship
existed between insurance primary payer status (Medicare, Medicaid, uninsured, or
private insurance) and 30-day readmission rates among individuals whose primary or
secondary reason for admission was T2DM nationally. It was observed that possession of
Medicare and lack of insurance was significant predictors of being readmitted within 30
days.
The null hypothesis was also retained for RQ2. Sociodemographic factors like
age, gender, and income did not moderate the relationship between insurance primary
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payer status like Medicare, Medicaid, uninsured, or private insurance) and 30-day
hospital readmission rates among individuals whose primary or secondary reason for
admission was T2DM nationally. When controlling for gender, females had a .91 (95%
CI: 0.87 – 0.95) times higher odds of being readmitted within 30 days, compared to
males.
The evidence collected and the data analyzed during this quality improvement
project added benefit to the advancement of research in this area. In the next section I
will expand on the findings, implications, and recommendations relating to the objective
of the research study were to determine whether there was a correlation between 30-day
readmission rates among patients whose primary or secondary reason for admission was
T2DM (i.e., diabetes) while controlling for multiple covariates as listed in the RQs.
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Section 4: Application to Professional Practice and Implications for Social Change
Introduction
In this chapter, I will further discuss the study findings and present
recommendations formulated as an outcome of the research study. Hospital readmission
within 30 days of discharge is a significant topic of health care reform in the United
States. Reforms can include implementing protocols prior to discharge that may prevent
possible readmissions and possibly reduce the cost to both the facility and the patient. A
facility’s 30-day readmission rate encompasses all unplanned readmissions that occur
within 30 days of discharge regardless of the cause (CMS, 2013). The risk index includes
patients who are readmitted to the same hospital or another acute care hospital for any
reason regardless of their primary diagnosis (CMS, 2013). The measures do not include
planned readmissions. Currently, CMS measures hospital performance in the HRRP by
calculating ERRs for each of the program measures.
The quantitative cross-sectional study looked at patients who experienced 30day readmissions to hospitals nationally in 2015 for a primary or secondary reason of
T2DM. Logistic regression was used to analyze data to find a correlation between the
independent variables of primary payer status (Medicare, Medicaid, uninsured, or private
insurance) and the dependent variable of hospital readmission rate. Results of logistic
regression analysis showed that possession of Medicare and lack of insurance were
significant predictors of being readmitted within 30 days. Women had higher odds of
being readmitted within 30 days compared to men.
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Interpretation of the Findings
Findings from this quantitative research study revealed that the largest income
bracket was $1-$41,999 range (34.1%), that majority of the participants (53.8%) were
female, and that the age range of all participants was between 20-90 years old (M =
67.26, SD = 15.68). Most participants had Medicare (67.9%). An additional analysis
revealed that much of the sample identified had diabetes with complications (62.1%). The
data analysis showed there was no statistically significant relationship between primary
payer status and 30-day readmission rates among individuals whose primary or secondary
reason for admission was T2DM nationally. Participants with Medicare and those without
insurance were significant predictors of being readmitted within 30 days.
Sociodemographic factors like age, gender, and income do not moderate the relationship
between primary payer status and 30-day hospital readmission rates among individuals
whose primary or secondary reason for admission was T2DM nationally. Women had
higher odds of being readmitted within 30 days compared to men. These findings implied
that the control health systems have achieved substantial improvements in readmission
rates among patients with T2DM is limited. More work is needed to distinguish the
expected impact of intrinsic hospital traits versus quality improvement strategy
implementation particularly when considering how costly implementation of strategies
can be in a resource-limited environment (Bennett, et al., 2020).
Limitations of the Study
This doctoral research study was subject to some limitations. One very significant
limitation was the use of the HCUP NRD (2015), which is a very large public data set.
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When using large data sets, researchers often face issues with accuracy (Smith, et al.,
2011). The source of the data input for the NRD came from a host of state-level
affiliates. Even though the NRD strives for consistency of its affiliates, the consistency of
the submission often comes with challenges such lack of control over variables and data.
Large sample sizes may introduce bias, like errors in measurements, errors in sampling,
and systematic omission of essential information (Kaplan, Chambers, & Glasgow, 2014).
Current literature also identifies the limits of administrative data (Harron, et al., 2017). It
is important that the data collection and the data analysis are consistent and/or in
alignment when using large data sets. This is not always the case. The difficulty in the
coding process and the expertise of the coders can also adversely affect the results of the
study. The impacts cannot be regulated or measured by the researcher, which is also a
limitation. Regardless of these limitations, I believe that this research should be deemed
original and indicative of the need for more meaningful research to be performed.
Recommendations
Patient education and care transitions are important in the reduction rate of 30-day
readmission rate for patients with T2DM. The present study’s time frame (FY2015) was
3 years after implementation of the HRRP in (2012), so the present results should be at
least somewhat indicative and representative of projected outcomes of the HRRP, after
adequate implementations have taken place. A mixed-methods study on comorbidities
should also be conducted to see what role or if any percentage of underlying health
conditions are involved in the 30-day readmission rate of patients with T2DM. Hospital
administrators should conduct both internal and external surveys. The survey results may
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help connect hospital performance measures with the 30-day readmission rate. The prime
objective of administrators and personnel within hospitals is to provide impeccable
service to patients (Loria, 2018). Findings suggest that administrators and personnel
should continue their efforts to improve services. Internal surveying could also help
shape the climate and effectiveness of the working environment.
Implications for Professional Practice and Social Change
Methodological, Theoretical, and Empirical Implications
I used a quantitative design as this was the most appropriate research design for
studying the 30-day readmission rate for patients with T2DM and insurance payer status
and sociodemographic status of patients with T2DM. A statistical analysis was performed
for the HCUP NRD (2015). Income, insurance payer status, age, and gender were the
variables used to collect data. These variables were properly used for testing as they met
the qualifications and conditions for statistical analysis as it related to the research (see
Section 3). I did not find a significant predictor model. The results may therefore offer
limited applications for professional practice.
The conceptual framework used in this quantitative research study was the
Donabedian framework (Ayanian & Markel, 2016). Healthcare facilities may use the
model to exam health services and evaluate the quality of healthcare (Ayanian & Markel,
2016). A hospital administrator can utilize the concepts of the Donabedian model to
develop strategies and programs that may help the organization and the community
reduce the rate of 30-day readmissions for patients with T2DM.
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Positive Social Change
Evidence from this research may create positive changes by informing
administrators, healthcare professionals, and hospital leaders regarding the importance of
providing resources for patients with T2DM. Findings from the study may specifically
lead to positive social change by informing health care providers and administrators
regarding whether there is a correlation between health insurance payers and readmission
rates of patients with T2DM. Healthcare providers and leaders can create programs to
ensure that all patients with a primary or secondary diagnosis of diabetes receive
appropriate care and education to reduce readmissions, improve health outcomes, and
improve quality of life for this patient population, which may result in significant
financial savings for patients and healthcare facilities.
Administrators can potentially use the findings of the study to decrease hospital
readmission rates of patients with T2DM by providing thorough after-care instruction for
the lay person. According to experts, providers should encourage follow-up care with
primary care physician at least a week after discharge for T2DM treatment (Loria, 2018).
The hospital and the patient must work as a team to reduce hospital readmissions and
costs to both the hospital and the patient (Loria, 2018).
Conclusion
Thirty-day hospital readmission rates are an important performance indicator for
hospitals in the United States (Gerhardt et al., 2012). The government put policies such as
HRRP in place to encourage hospitals to find strategies to reduce excessive readmission
rates. At the time of this study, these policies have been somewhat effective in achieving
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their specified goal (Ferro, et al., 2019). Current regulations indicate that the hospital is
the primary stakeholder in the healthcare equation in decreasing 30-day readmission
rates. However, this study showed that hospitals can affect only a small proportion of
readmission rates. The current policy does not take into consideration many of the
readmission-driving factors that are not modifiable by the hospital in its readmission rate
calculations despite recognition of these factors by key policy makers study.
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Appendix: Literature Review Matrix
Literature Matrix
Study Authors

Sample

Variables

Type of study

Outcomes

Alavi, Baharlooei, &
AdelMehraban, 2017

150

DVReadmission
Rate
IV-gender,
marital status,
education,
income, age,
depression,
anxiety, stress,
and social
support

Cross-sectional
analysis

Programs to
improve mental
health of the
elderly and
development of
social support
network are
suggested to
help reduce the
risk of
readmission
among diabetic
elderly patients.
More studies
are needed to
facilitate this
change

Assari, Moghani
Lankarani, Piette, &
Aikens, 2017
Looked at
socioeconomic status
(SES) and HbA1c
levels of black and
white, male and female
participants, to attempt
to find a correlation
between SES status
and HbA1c.

112

DV-SES
IV- HbA1c, sex,
race

Cross-sectional
analysis

SES has a
greater effect
on black males
with diabetes.
Due to the
small sample
population of
the study, more
research is
needed

84
Bird, Lemstra,
Rogers, & Moraros,
2015
Analyzed data from
four cycles of the
Canadian Community
Health Survey to
determine the adjusted
and unadjusted effects
on income of patient
with Type 2 diabetes

27,090

Cross-sectional
population based
study

Income was
closely and
independently
associated with
Type 2 diabetes

Busby et al., 2015
A systematic review of
the scale and reason of
geographical
differences in
unplanned hospital
admission rates &
length of stay for
ambulatory care

43,819

DV – LOS
IV – Admission
rates

Cross-sectional
analysis

Differences in
admission rate
fewer
admission
causing shorter
LOS

Comino et al., 2015
Looked at individual
patient characteristics
and hospital-level
factors affecting the
length of stay and total
cost of hospitalization

162
Counties
6 states

DV-Inpatient
Multivariate
cost
analysis
IV- Geographical Linear regression
location

Prices are
significantly
higher for
private vs.
Medicare.
Payment
policies from
Medicare affect
private payers.
Public policy
that takes into
consideration
the marketbased approach
or payment
reform to
reduce price
variation
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181 284
Everett &
DKA
Mathioudakis, 2019
Looked at the
admissions
readmission rate of
patients with Diabetic
Ketoacidosis (DKA)
while primarily
focusing on the
socioeconomic
indicator of the patients

DVSocioeconomic
status
IV- Readmission
rate DKA

Cross- sectional
analysis

Multivariate
analysis

Qureshi, Adil,
Zacharatos & Suri
2013
Identified the factors of
prolonged
hospitalization while
concurrently trying to
determine the effect of
hospital charges

385

DV- Length of
stay
IV-Hospital
charges

Raval, et al., 2015)
Looked at the 30-Day
Readmission Among
Elderly Medicare
Beneficiaries with
Type 2 Diabetes

202,496
elderly
Medicare
recipients
with Type
2 DM

DV-Readmission Multivariable
days IVlogistic
Demographics,
regression
insurance,
hospitalization
index,
clinical
characteristics
elderly specific
complexities, i.e.
fall risk cognitive
impairments,
urinary
incontinence

Lower
socioeconomic
status and
government
insurance are
strong
predictors of
DKA
readmissions in
adults with type
1 diabetes in
the USA.
More studies
are needed to
determine what
can lead to the
reduction of
length of stay

Intervention
programs to
reduce the risk
of readmissions
among elderly
patients with
T2DM might
need to be
tailored to suit
the needs of
elderly patients

86
Rubin, Sherita,
McDonnell, & Zhoa,
2017
Looked at medical
records of the patients
from Boston Medical
Center that were
discharged been
January 2004 and
December 2012 to
develop a tool Diabetes
Early Readmission
Risk Indicator CVA
(DEERITM-CVD) that
predicts 30-d
readmission risk for
diabetic patient’s
hospitalized for
cardiovascular disease

8189
electronic
medical
records

DV-CVA
patients
IV-Education
level,
employment,
pre- admission
diabetes, diabetes
complications,
creatinine and
bun levels at
admissions,
recent hospital
discharge

Multivariable
logistic
regression
analysis

The DEERITMCVD may be a
useful tool in
predicting the
cause of 30-d
readmission
patients with
diabetes
hospitalized for
CVD. This tool
can help with
lowering
healthcare
cause by
identifying
patients that are
high risk and
targeting those
patients for
better
healthcare
outcomes

Sonmez, Kambo,
Avtanksi, Lutsky, &
Poretsky, 2017
Compared the
readmission rate for
patients with the
secondary diagnosis of
diabetes, while also
looking at the
association between the
length of stay
and readmission rates
in patients with
diabetes and those
without

102,694
16,266
with
diabetes

DVReadmission rate
with/without
diabetes
IV- Length of
stay, sex, age,
secondary
diagnosis
diabetes, primary
diagnosis
diabetes

Logistic
regression
analysis

30-day
readmission
rates are higher
in patients
with DM
compared to
patients without
DM regardless
of age and
gender;
readmission
rates are
significantly
higher in male
patients and
patients greater
than 65 years
old.

